Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SwiftPharma poliovirus vaccine
- Development stage
- Preclinical
- Lead developer
- SwiftPharma
- Modality
- Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Cancer Vaccines → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Recombinant Protein Vaccines → Recombinant Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
01
Overview
SwiftPharma poliovirus vaccine is a virus-like particle (VLP) vaccine candidate currently in the discovery phase for the prevention of poliomyelitis. Developed using SwiftPharma's proprietary plant-based expression system, the vaccine utilizes highly mannosylated VLPs that structurally mimic the poliovirus to elicit a robust immune response. Because VLPs do not contain the viral genome, the vaccine aims to provide a safer alternative to traditional live-attenuated or inactivated vaccines by eliminating the risk of vaccine-derived poliovirus (VDPV) or incomplete inactivation.
- Other names
- poliovirus vaccine-SwiftPharma-VLP vaccine-PoliovirusSwiftPharma VLP poliovirus vaccinePoliovirus VLP vaccine
Beyond the preview
Go deeper on SwiftPharma poliovirus vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SwiftPharma poliovirus vaccine.